Cargando…

HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy

Peroxisome proliferator-activated receptors (PPARs) regulate cardiac glucose and lipid homeostasis. Histone deacetylase (HDAC) inhibitor has anti-inflammatory effects which may play a key role in modulating PPARs and fatty acid metabolism. The aim of this study was to investigate whether HDAC inhibi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Ting-I, Kao, Yu-Hsun, Tsai, Wen-Chin, Chung, Cheng-Chih, Chen, Yao-Chang, Chen, Yi-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944062/ https://www.ncbi.nlm.nih.gov/pubmed/27446205 http://dx.doi.org/10.1155/2016/5938740

Ejemplares similares

PPARs modulate cardiac metabolism and mitochondrial function in diabetes
por: Lee, Ting-Wei, et al.
Publicado: (2017)

Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021)

Ketogenic Diet Regulates Cardiac Remodeling and Calcium Homeostasis in Diabetic Rat Cardiomyopathy
por: Lee, Ting-I, et al.
Publicado: (2023)

Empagliflozin suppressed cardiac fibrogenesis through sodium-hydrogen exchanger inhibition and modulation of the calcium homeostasis
por: Chung, Cheng-Chih, et al.
Publicado: (2023)

Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
por: Cheng, Wan-Li, et al.
Publicado: (2021)

Lithium Reduces Migration and Collagen Synthesis Activity in Human Cardiac Fibroblasts by Inhibiting Store-Operated Ca(2+) Entry
por: Chen, Pao-Huan, et al.
Publicado: (2021)

Empagliflozin Attenuates Myocardial Sodium and Calcium Dysregulation and Reverses Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats
por: Lee, Ting-I, et al.
Publicado: (2019)

SHSST Cyclodextrin Complex Prevents the Fibrosis Effect on CCl(4)-Induced Cirrhotic Cardiomyopathy in Rats through TGF-β Pathway Inhibition Effects
por: Yang, Cheng-Hsun, et al.
Publicado: (2014)

Fibroblast Growth Factor 23 Stimulates Cardiac Fibroblast Activity through Phospholipase C-Mediated Calcium Signaling
por: Lee, Ting-Wei, et al.
Publicado: (2021)

Reactivation of PPARα alleviates myocardial lipid accumulation and cardiac dysfunction by improving fatty acid β-oxidation in Dsg2-deficient arrhythmogenic cardiomyopathy
por: Lin, Yubi, et al.
Publicado: (2023)

Lithium Treatment Improves Cardiac Dysfunction in Rats Deprived of Rapid Eye Movement Sleep
por: Chen, Pao-Huan, et al.
Publicado: (2022)

Klotho Modulates Pro-Fibrotic Activities in Human Atrial Fibroblasts through Inhibition of Phospholipase C Signaling and Suppression of Store-Operated Calcium Entry
por: Hung, Yuan, et al.
Publicado: (2022)

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shang-Chin, et al.
Publicado: (2021)

Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy
por: Qiu, Zirui, et al.
Publicado: (2022)

HDAC2 and HDAC5 Up-Regulations Modulate Survivin and miR-125a-5p Expressions and Promote Hormone Therapy Resistance in Estrogen Receptor Positive Breast Cancer Cells
por: Huang, Wen-Tsung, et al.
Publicado: (2017)

Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα
por: Yang, Jing, et al.
Publicado: (2016)

PPARs and Metabolic Syndrome
por: Chen, Lihong, et al.
Publicado: (2014)

Sex and Age Differences Modulate Association of Vitamin D with Serum Triglyceride Levels
por: Cheng, Ying-Lien, et al.
Publicado: (2022)

HDAC Inhibitors and RECK Modulate Endoplasmic Reticulum Stress in Tumor Cells
por: Chen, Yun, et al.
Publicado: (2017)

Very-Low-Density Lipoprotein of Metabolic Syndrome Modulates Gap Junctions and Slows Cardiac Conduction
por: Lee, Hsiang-Chun, et al.
Publicado: (2017)

Traditional Chinese Medication Qiliqiangxin Attenuates Diabetic Cardiomyopathy via Activating PPARγ
por: Wu, Xiaodong, et al.
Publicado: (2021)

PPARγ Modulates Long Chain Fatty Acid Processing in the Intestinal Epithelium
por: Duszka, Kalina, et al.
Publicado: (2017)

Glucagon‐like peptide‐1 ameliorates cardiac lipotoxicity in diabetic cardiomyopathy via the PPARα pathway
por: Wu, Lujin, et al.
Publicado: (2018)

Inhibitory effect of PPARγ on NLRP3 inflammasome activation
por: Yang, Ching-Chun, et al.
Publicado: (2021)

Fibroblast growth factor 23 dysregulates late sodium current and calcium homeostasis with enhanced arrhythmogenesis in pulmonary vein cardiomyocytes
por: Huang, Shih-Yu, et al.
Publicado: (2016)

Novel Selective PPARα Modulator Pemafibrate for Dyslipidemia, Nonalcoholic Fatty Liver Disease (NAFLD), and Atherosclerosis †
por: Yamashita, Shizuya, et al.
Publicado: (2023)

Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: King, Jacob, et al.
Publicado: (2021)

Effect of Astaxanthin on the Inhibition of Lipid Accumulation in 3T3-L1 Adipocytes via Modulation of Lipogenesis and Fatty Acid Transport Pathways
por: Tsai, Mei-Chih, et al.
Publicado: (2020)

The Cell Protective Effect of Adenine on Hypoxia–Reoxygenation Injury through PPAR Delta Activation
por: Leu, Jyh-Gang, et al.
Publicado: (2021)

The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity
por: Karwi, Qutuba G., et al.
Publicado: (2021)

Expression of Concern on “Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα”
por: PPAR Research,
Publicado: (2019)

Effects of PPARs Agonists on Cardiac Metabolism in Littermate and Cardiomyocyte-Specific PPAR-γ –Knockout (CM-PGKO) Mice
por: Barbieri, Michelangela, et al.
Publicado: (2012)

Peroxisome Proliferators-Activated Receptor (PPAR) Modulators and Metabolic Disorders
por: Cho, Min-Chul, et al.
Publicado: (2008)

Disturbed Cardiac Metabolism Triggers Atrial Arrhythmogenesis in Diabetes Mellitus: Energy Substrate Alternate as a Potential Therapeutic Intervention
por: Lkhagva, Baigalmaa, et al.
Publicado: (2022)

Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52
por: Chen, Chin-Chuan, et al.
Publicado: (2017)

Carnitine regulates myocardial metabolism by Peroxisome Proliferator-Activated Receptor-α (PPARα) in alcoholic cardiomyopathy
por: Jing, Ling, et al.
Publicado: (2011)

STAT6 contributes to renal fibrosis by modulating PPARα-mediated tubular fatty acid oxidation
por: Li, Jianzhong, et al.
Publicado: (2022)

The Effects of PPAR Stimulation on Cardiac Metabolic Pathways in Barth Syndrome Mice
por: Schafer, Caitlin, et al.
Publicado: (2018)

Inguinal Fat Compensates Whole Body Metabolic Functionality in Partially Lipodystrophic Mice with Reduced PPARγ Expression
por: Chang, Cherng-Shyang, et al.
Publicado: (2023)

SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women
por: Lai, Liang-Chuan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_kbqrrc7ooc9tabdn6jkvm8bcto